US Bancorp’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-81
Closed -$122 4302
2025
Q1
$122 Sell
81
-185
-70% -$467 ﹤0.01% 4134
2024
Q4
$628 Sell
266
-57
-18% -$1K ﹤0.01% 4009
2024
Q3
$9.51K Sell
323
-279
-46% -$6.42K ﹤0.01% 3381
2024
Q2
$7.43K Sell
602
-2,303
-79% -$48.5K ﹤0.01% 3407
2024
Q1
$58.9K Sell
2,905
-128
-4% -$2.95K ﹤0.01% 2601
2023
Q4
$68.3K Buy
3,033
+361
+14% +$7.63K ﹤0.01% 2510
2023
Q3
$44.5K Sell
2,672
-4,886
-65% -$96.8K ﹤0.01% 2506
2023
Q2
$185K Buy
7,558
+105
+1% +$2.53K ﹤0.01% 1903
2023
Q1
$180K Sell
7,453
-778
-9% -$21.6K ﹤0.01% 1909
2022
Q4
$243K Buy
8,231
+1,477
+22% +$53.1K ﹤0.01% 1753
2022
Q3
$282K Buy
6,754
+1,715
+34% +$46.3K ﹤0.01% 1671
2022
Q2
$142K Buy
5,039
+799
+19% +$20.2K ﹤0.01% 2036
2022
Q1
$157K Buy
4,240
+482
+13% +$20.4K ﹤0.01% 2072
2021
Q4
$164K Buy
3,758
+342
+10% +$17.9K ﹤0.01% 2058
2021
Q3
$212K Buy
3,416
+1,925
+129% +$161K ﹤0.01% 1941
2021
Q2
$127K Buy
1,491
+891
+149% +$47.7K ﹤0.01% 2180
2021
Q1
$27K Buy
+600
New +$23.6K ﹤0.01% 2890

Other funds holding FLNA